How real-world research can streamline post-marketing studies in oncology (01:00:40)

How real-world research can streamline post-marketing studies in oncology (01:00:40)

Flatiron Health

Topic

Starts3 April 2026

With growing complexity of post-marketing requirements and commitments in oncology putting strain on the already stretched clinical research ecosystem, real-world research is well suited to bridge the gap between care and research.

In this webinar, experts from The Reagan-Udall Foundation for the FDA, Flatiron Health, and Johnson & Johnson:

  • Highlight the value of post-marketing studies and key frameworks for efficient and impactful evidence generation
  • Present an overview of PMR/PMCs in oncology and opportunities for real-world evidence generation approaches
  • Share examples of more pragmatic approaches to PMR/PMCs

Organisation

Flatiron Health Logo
Flatiron Health
FLATIRON HEALTH® is a healthtech company dedicated to improving cancer treatment and advancing research. As the pioneer in real-world evidence for oncology, they provide technology and services to support patient care and make every person’s story count. They partner with hundreds of cancer centers, 20+ top global developers of oncology therapeutics, and researchers and regulators around the world.